Fluoroquinolone Antibiotics Linked to Aortic Aneurysm and Dissection
In December 2018, the U.S. Food and Drug Administration (FDA) warned that fluoroquinolone antibiotics can double patients’ risks of suffering potentially deadly ruptures and tears in their aortas, also known as aortic dissection or ruptured aortic aneurysm. The increased risk is found in patients who take the medications orally and intravenously.
Because of the FDA’s findings, fluoroquinolone antibiotics will be required to have new warnings added to their prescribing information and patient medication guides. In addition, the FDA recommends that fluoroquinolone antibiotics not be given to patients with increased risk factors unless no other treatment options are available.
Who Is Most at Risk?
The FDA’s commissioner stated that certain patients may be more at risk for antibiotic-related aortic tears, ruptures, dissections, and ruptured aneurysms, including:
- Elderly patients
- Patients with a history of blockage of the aorta or other blood vessels
- Patients with high blood pressure
- Patients with genetic conditions that involve blood vessel changes, including Marfan syndrome and Ehlers-Danlos syndrome
- Patients with a history of aortic aneurysm
Patients who experience symptoms such as sudden and severe pain in their stomachs, chests, or backs should seek immediate medical attention.
Which Medications Increase Patients’ Risks?
Fluoroquinolone antibiotics have been used for more than 30 years to treat bacterial infections. Popular brand names of medications associated with increased aortic dissection and ruptured aneurysm risks include:
Patients currently taking any of those medications shouldn’t stop without first talking to their doctors.
Hurt by Fluoroquinolone Antibiotics? We’re Here to Help.
At Dudley DeBosier, our Baton Rouge drug injury attorneys stand up to big pharmaceutical companies when their medications put innocent patients’ health and lives at risk.
If you or someone you love suffered an aortic rupture, tear, or dissection after taking fluoroquinolone antibiotics, you may be eligible for compensation. Contact us today for a free consultation to find out how we can help you get the money you deserve.
Avelox® is a registered trademark of Bayer Healthcare Pharmaceuticals, Inc. Baxdela® is a registered trademark of Melinta Therapeutics. Cipro® is a registered trademark of Bayer Healthcare Pharmaceuticals, Inc. Factive® is a registered trademark of Merus Labs International, Inc. Floxin® is a registered trademark of Janssen Pharmaceuticals, Inc. Levaquin® is a registered trademark Janssen Pharmaceuticals, Inc. Noroxin® is a registered trademark of Merck & Co., Inc.
Dudley DeBosier is not associated with, sponsored by, or affiliated with the U.S. Food and Drug Administration, Bayer Healthcare Pharmaceuticals, Inc., Melinta Therapeutics, Merus Labs International, Inc., Janssen Pharmaceuticals, Inc., and Merck & Co., Inc.